baber/WOPTO huggingface dataset:
Patent AU-2010211102-B2 (AU)
Title: A pipe or cable lead-through having layers of different thickness
Inventor: ANDERSSON JENS
IPC: F16L5/00
Filed: 2010-02-02
Granted: 2014-07-10
Abstract: A compressible seal or lead-through for cables, wires or pipes. The seal has two or more base parts (1, 8, 11) surrounding each cable, wire or pipe. Each compressible base part (1, 8, 11) has peelable sheets (3-7, 10, 12) for adapting to the diameter of a cable, wire or pipe. The sheets (3-7, 10, 12) placed in the base parts (1, 8, 11) have either different thicknesses or different rigidities.
Patent AU-2010213547-B2 (AU)
Title: Aggregation of physical layer information related to a network
Inventor: RAZA MOHAMMAD
IPC: H04L69/14
Filed: 2010-02-12
Granted: 2015-05-14
Abstract: An exemplary system includes a plurality of connector assemblies. Each of the connector assemblies includes a plurality of ports. Each of the connector assemblies is configured to read information stored on or in physical communication media that is connected to the ports of the respective connector assembly. An aggregation point is communicatively coupled to the plurality of connector assemblies. The aggregation point is configured to automatically discover the connector assemblies and cause each of the connector assemblies to send to the aggregation point at least some of the information read from the physical communication media that is connected to its ports. The aggregation point is configured to store at least some of the information sent by the connector assemblies to the aggregation point. The aggregation point can also be configured to provide at least some of the information it stores to at least one other device via the network.
Patent AU-2010218284-B2 (AU)
Title: Self-limiting electrosurgical return electrode with pressure sore reduction and heating capabilities
Inventor: ARAMAYO THOMAS F
IPC: A61B18/16
Filed: 2010-02-18
Granted: 2014-07-10
Abstract: A self-limiting electrosurgical electrode for use with electrosurgery and various other surgical procedures is disclosed. The electrode includes a heating element for generating heat to warm a patient resting upon the electrode. The electrode can also include one or more pads to prevent the creation of pressure sores or decubitus ulcers on a patient resting upon the electrode. The electrode has an effective bulk impedance equal to or greater than about 4,000 Ω.cm, which arises from resistive components, capacitive components, inductive components, or combinations thereof. Through the selection of the impedance characteristics for the electrode materials, and through tailoring of electrode geometries, the electrode of the present invention is self-regulating and self- limiting as to current density and temperature rise so as to prevent patient trauma.
Patent AU-2010219518-B2 (AU)
Title: Anti-Rhesus D monoclonal antibody
Inventor: GAUCHER CHRISTINE
IPC: A61P37/00
Filed: 2010-03-05
Granted: 2012-09-20
Abstract: The invention relates to an anti-RhD monoclonal antibody that consists of a tetrameric immunoglobulin IgGI with two heavy chains and two light chains, the heavy chain including the amino acid sequence SEQ ID N°2 with a phenylalanine residue at position 68, and the light chain including the amino acid sequence SEQ ID N°4.
Patent AU-2010239795-B2 (AU)
Title: Method of preparing low-iron lactoferrin
Inventor: PEARCE KEVIN NEIL
IPC: A23J3/32
Filed: 2010-04-23
Granted: 2014-07-10
Abstract: The present invention relates to methods for producing low-iron Lf having improved antimicrobial activity and to a low-iron Lf having improved antimicrobial activity.
Patent AU-2010297510-B2 (AU)
Title: Water dispersible, cyclic-carbonate-functionalized vinyl copolymer system
Inventor: MECFEL-MARCZEWSKI JOANNA
IPC: C08F220/18
Filed: 2010-08-12
Granted: 2014-09-25
Abstract: The invention relates to a water dispersible, cyclic-carbonate-functionalized vinyl copolymer binding agent, to a method for producing the binding agent, to an aqueous dispersion comprising the binding agent, to a system comprising the binding agent, water and an (amine) hardener, and to the use of the binding agent to produce a hardened coating. It was surprisingly found that said binding agent, in which the emulsifier groups according to the invention are integrated in the polymer chain, results in stable aqueous dispersions having a solid matter content of up to > 30% by weight.
Patent AU-2010312263-B2 (AU)
Title: Gallotannic compounds for lithographic printing plate coating compositions
Inventor: NGUYEN MY T
IPC: C09K23/00
Filed: 2010-06-11
Granted: 2013-10-03
Abstract: There is provided a gallotannic compound, a method of producing a gallotannic compound, a lithographic printing plate coating composition, a lithographic printing plate, a method of producing a lithographic printing plate and a method of printing.
Patent AU-2010312403-B2 (AU)
Title: Toner, image forming apparatus, image forming method and process cartridge
Inventor: FUKAO TOMOHIRO
IPC: G03G9/08
Filed: 2010-10-27
Granted: 2013-08-01
Abstract: A toner including a binder resin, a colorant and protruding portions on a surface of the toner, wherein the average length of long sides of the protruding portions is 0.1 μm or greater, but less than 0.5 μm, wherein the standard deviation of the lengths of the long sides of the protruding portions is 0.2 or less, and wherein the protruding portions have a coverage of 30% to 90%.
Patent AU-2010333083-B2 (AU)
Title: 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
Inventor: DANNHARDT GERD
IPC: C07D471/04
Filed: 2010-12-10
Granted: 2016-02-25
Abstract: The present invention relates to a compound of formula (I) wherein R
Patent AU-2011237798-B2 (AU)
Title: Aseptic fluid connector
Inventor: PY DANIEL
IPC: A61M3/00
Filed: 2011-04-05
Granted: 2014-06-26
Abstract: An aseptic fluid connector having a first connector including a first fluid passageway for receiving a fluid therein; a first port in fluid communication with the first fluid passageway for passage of the fluid therethrough; and a first deflecting member. The first deflecting member includes a first engaging portion radially spaced relative to the first port, and a first valve movable between a closed position and an open position with movement of the first engaging portion between a non-deflected position and a deflected position, respectively, in the non- deflected position, the first valve is located in the closed position forming a fluid-tight seal between the first valve and first port and preventing the passage of fluid therethrough, and in the deflected position, the first valve is located in the open position allowing the aseptic passage of fluid through the first port.
Patent AU-2011301985-B2 (AU)
Title: Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
Inventor: OSORIO IVAN
IPC: A61N1/36
Filed: 2011-09-15
Granted: 2015-07-16
Abstract: Methods, systems, and apparatus for detecting and/or validating a detection of a state change by matching the shape of one or more of an cardiac data series, a heart rate variability data series, or at least a portion of a heart beat complex, derived from cardiac data, to an appropriate template.
Patent AU-2011306068-B2 (AU)
Title: Methods and compositions for treating lung cancer
Inventor: LIU SHENG-YUNG
IPC: A61K31/10
Filed: 2011-04-15
Granted: 2014-08-07
Abstract: The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds.
Patent AU-2011315938-B2 (AU)
Title: Biomarker and Method for Detecting a Chronic Inflammatory-Associated Disease
Inventor: PEREIRA HELOISE ANNE
IPC: C07K17/04
Filed: 2011-10-14
Granted: 2015-07-23
Abstract: The present invention in one embodiment uses detection of isoforms of CAP37 in a fluid as an early detection marker for a chronic inflammatory- associated disease. Chronic inflammatory-related diseases may include, for example, atherosclerosis, psoriasis, osteoarthritis, and Alzheimer's disease. The invention is also directed to isoforms of CAP37 protein having apparent molecular weights of about 135 kDa (± 15 kDa) and about 100 kDa (± 15 kDa) as assessed by SDS PAGE under reducing conditions, and their use as biomarkers for the presence of a chronic inflammatory-associated disease in a subject. The invention is also directed to monoclonal and/or polyclonal antibodies raised against such isoforms of CAP37 protein and kits and diagnostic tests comprising these antibodies.
Patent AU-2011323111-B2 (AU)
Title: Improved algorithm for detection of diabetes
Inventor: IGNOTZ KEITH D
IPC: A61B5/02
Filed: 2011-11-07
Granted: 2015-06-11
Abstract: Methods for spectroscopic analysis of biological tissues to classify an individual as diabetic or non-diabetic, or to determine the probability, progression or level of a disease or medical condition in an individual.
Patent AU-2011342980-B2 (AU)
Title: Hair styling device
Inventor: DE BENEDICTIS ALFREDO
IPC: A45D2/12
Filed: 2011-12-16
Granted: 2014-07-17
Abstract: This invention relates to a hair styling device (10) having a body (12) defining a chamber (16) adapted to accommodate a length of hair (26), the length of hair being styled whilst it is located within the chamber. The chamber has a primary opening (24) through which the length of hair may pass into the chamber. A rotatable element (34) is provided which is adapted to engage the length of hair adjacent to the primary opening. An elongate member (20) is located within the chamber (16), the length of hair being wound around the elongate member by the rotatable element. The device has a handle (14) which may be gripped by a user, the handle comprising a first handle part (62) and a second handle part (60), the first handle part (62) being connected to the body (12) and the second handle part (60) being movable relative to the first handle part (62). The second handle part can carry a panel (56) which is adapted to close the primary opening (24).
Patent AU-2011347086-B2 (AU)
Title: DNA expression construct
Inventor: SCHROFF MATTHIAS
IPC: C12N15/11
Filed: 2011-12-23
Granted: 2015-07-16
Abstract: The invention relates to a minimalistic gene expression construct, its transfer into cells and its use for gene expression for molecular-medical applications. According to the disclosure, a DNA construct for gene expression is provided, wherein the construct is a linear and open-chained DNA double strand comprising a promoter sequence, a coding sequence and a termination signal, wherein the construct comprises at least one L-DNA nucleotide.
Patent AU-2011354196-B2 (AU)
Title: Adaptor means for use in combination with a pre-filled syringe and a safety device, safety device and injection device
Inventor: ROBERTS GARETH
IPC: A61M5/32
Filed: 2011-12-30
Granted: 2015-12-17
Abstract: According to the invention, an adaptor means (1) for use in combination with a pre-filled syringe (2) and a safety device (3) for the pre-filled syringe (2) is adapted to affix the pre-filled syringe (2) thereto, whereby the adaptor means (1) engages a barrel (2.1) of the pre-filled syringe (2). The adaptor means (1) comprises at least one locking projection (1.1.1) that is adapted to lock the adaptor means (1) to the safety device (3).
Patent AU-2011362626-B2 (AU)
Title: Acoustic signal processing using model-based adaptive filtering
Inventor: MANDAL BATAKRISHNA
IPC: G01V1/36
Filed: 2011-03-15
Granted: 2014-08-21
Abstract: A method of processing acoustic waveform data is disclosed. An acoustic logging tool acquires acoustic waveform data. An adaptive frequency filter is determined. The acoustic waveform data is filtered using the adaptive frequency filter. A formation slowness is determined from the filtered acoustic waveform data. The lower bound of the adaptive frequency filter may be determined using a polynomial function of a minimum excitement frequency parameter, a slowness parameter, and a third parameter. The upper bound of the adaptive frequency filter may be determined using a polynomial function of a peak excitement frequency parameter, the slowness parameter, and the third parameter.
Patent AU-2011380375-B2 (AU)
Title: Method for preparing edge-rigidized artificial biological valve
Inventor: CHEN DAKAI
IPC: A61L27/00
Filed: 2011-12-14
Granted: 2015-09-17
Abstract: A method for preparing an edge-rigidized artificial biological valve comprising: first soaking an artificial biological valve in a pretreated glutaraldehyde solution, wherein the artificial biological valve can be partly fixed with glutaraldehyde before, after or during contact with the pretreated glutaraldehyde solution; and then closing the free aldehyde groups, carboxyl groups, amino groups, hydroxyl groups and carbonyl groups formed by the artificial biological valve pretreated with glutaraldehyde with a reducing agent and tannin extract. The edge rigidity of the artificial biological valve is enhanced, so that the long-term stability and durability of the artificial biological valve are improved.
Patent AU-2011383747-B2 (AU)
Title: Method and computer program for monitoring use of an absorbent product
Inventor: CARNEY JOSHUA
IPC: A61F13/42
Filed: 2011-12-21
Granted: 2014-11-13
Abstract: The present invention provides a method for monitoring use of an absorbent product, such as an incontinence pad or a diaper, worn by a wearer. The method comprises the steps of registering (S4) a movement of the wearer by means of a mobile device (1) comprising a movement sensing device (2), evaluating (S5) whether the registered movement is indicative of urinary and/or faecal voiding by the wearer, and providing (S6) product-related information to the wearer or a caregiver of the wearer based on said evaluation. In this way, the product-wearer or his caregiver can be provided with valuable information related to the use of the product, for example recommendations on when to change the product, displayed on the mobile device or a mobile device of the caregiver.
Patent AU-2012216694-B2 (AU)
Title: Body-associated receiver and method
Inventor: ROBERTSON TIMOTHY
IPC: H04B13/00
Filed: 2012-09-06
Granted: 2016-01-14
Abstract: Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.
Patent AU-2012237066-B2 (AU)
Title: Pharmaceutical composition for preventing or treating macular degeneration
Inventor: YI KYU-YANG
IPC: A61P27/02
Filed: 2012-03-29
Granted: 2016-08-25
Abstract: The present invention relates to a pharmaceutical composition for preventing or treating macular degeneration. The pharmaceutical composition of the present invention contains, as an active ingredient, benzopyrane derivatives substituted with secondary amines including imidazole, or the pharmaceutically acceptable salts thereof. The pharmaceutical composition of the present invention may be used in the form of eye drops.
Patent AU-2012244212-B2 (AU)
Title: A cleaning device and method
Inventor: VAN DAM BRENDAN
IPC: E01H1/02
Filed: 2012-10-25
Granted: 2013-02-21
Abstract: A cleaning device 10, including at least one brush 16, 18. In use, the at least one brush 16, 18 is connected to a trailer 26. The device 10 is transportable on the trailer for transporting to a desired cleaning location.
Patent AU-2012269722-B2 (AU)
Title: Method and apparatus for identifying pulses in detector output data
Inventor: MANTON JONATHAN HUNTLEY
IPC: G01D21/00
Filed: 2012-06-14
Granted: 2015-12-03
Abstract: A method for locating a pulse in detector output data, comprising fitting one or more functions to the detector output data; and determining a location and an amplitude of a peak of said pulse from said one or more functions. The one or more functions may be are a function of time.
Patent AU-2012280476-B2 (AU)
Title: System and method for injecting a treatment fluid into a wellbore and a treatment fluid injection valve
Inventor: KLOMPSMA DERK LUCAS
IPC: E21B34/10
Filed: 2012-06-29
Granted: 2016-02-25
Abstract: The present invention provides a valve and method for injecting a treatment fluid into a production zone of a hydrocarbon production well. The valve comprises a tubular housing comprising a housing axial fluid passage, a fluid inlet being in fluid communication with the housing axial fluid passage, and a lateral fluid outlet; a sleeve member having a sleeve axial fluid passage and at least one lateral fluid opening, the sleeve member being fixedly arranged within the tubular housing, wherein the sleeve axial fluid passage is aligned with the housing axial fluid passage, and wherein the at least one lateral fluid opening is aligned with the lateral fluid outlet; and a piston member being moveably disposed within the sleeve axial fluid passage between a closed position and an open position, wherein the piston member in the closed position blocks treatment fluid flow from the housing axial fluid passage toward the sleeve axial fluid passage, and wherein the piston member in the open position permits treatment fluid flow from the fluid inlet through the housing axial fluid passage, the sleeve axial fluid passage, and the at least one lateral fluid opening in the sleeve member toward the lateral fluid outlet of the tubular housing.
Patent AU-2012302596-B2 (AU)
Title: Anti-human XCR1 antibodies
Inventor: SAKAMOTO YOSHIMASA
IPC: A61P37/00
Filed: 2012-08-30
Granted: 2016-12-01
Abstract: An object of the present invention is to provide a monoclonal antibody binding to human XCR1, wherein the antibody binds to linear or discontinuous epitopes which comprise at least three amino acids selected from the group consisting of the 8th, 11th, 12th, 13th, 14th, 16th, 17th, 22nd, 23rd, 176th, and 177th amino acids in the amino acid sequence of SEQ ID NO: 91.
Patent AU-2012347361-B2 (AU)
Title: Syringe carrier
Inventor: HOURMAND YANNICK
IPC: A61M5/24
Filed: 2012-12-05
Granted: 2017-05-25
Abstract: Described is a syringe carrier (1) comprising a body (1.1) adapted to receive a barrel (2.1) of a syringe (2). The body (1.1) includes an annular groove (1.19) formed in a distal end and adapted to receive a circlip (8) disposed in a circumferential gap between the barrel (2.1) of the syringe (2) and a needle shield (4) covering a needle (3) of the syringe (2).
Patent AU-2012393570-B2 (AU)
Title: Methods and systems for detecting epithermal and thermal neutrons
Inventor: GOODYEAR GRANT
IPC: G01T3/00
Filed: 2012-11-01
Granted: 2016-11-03
Abstract: A system includes a tool for measuring properties of a formation. The tool includes a tool body, a neutron source to emit neutrons disposed within the tool body, a neutron detector disposed within the tool body spaced apart from the neutron source, and a neutron shield arranged in operational relationship to the neutron detector, the neutron shield defines an exterior surface and an interior volume, the neutron shield to prevent neutrons having an energy below a first predetermined threshold from traveling from the exterior surface to the interior volume. The neutron shield is movably coupled to the tool body, wherein the neutron shield defines a non-occluded position relative to the neutron detector such that the neutron detector is at least partially outside the interior volume, and the neutron shield defines an occluded position relative to the neutron detector such that the neutron detector is disposed within the interior volume.
Patent AU-2013201274-B2 (AU)
Title: Electrosurgical power control
Inventor: LORANG DOUGLAS M
IPC: A61B18/12
Filed: 2013-03-05
Granted: 2014-06-05
Abstract: A method comprising: making one or more determinations that an impedance value encountered by an electrosurgical probe is less than a threshold value; and limiting tissue necrosis to less than 200 microns by delivering power to the electrosurgical probe, in response to at least one of the one or more determinations that the impedance is less than the threshold value, according to an algorithm that generates a signal with a pulsed power profile having low power portions and high power portions, wherein the high power portions have sufficient power to treat tissue in the desired manner.
Patent AU-2013203761-B2 (AU)
Title: Method and apparatus for channel encoding and decoding in a communication system using low-density parity-check codes
Inventor: MYUNG SEHO
IPC: H03M13/11
Filed: 2013-04-11
Granted: 2015-02-12
Abstract: Abstract A method for channel decoding using a Low-Density Parity-Check (LDPC) code, the method comprising: demodulating a signal transmitted from a transmitter; determining position information of punctured parity bits by estimating information about a predetermined 5 order of parity bit sets to be punctured and the number of parity bit sets; and decoding data using the positions of the punctured parity bits, wherein determining position information of punctured parity bits comprises: determining a number of parity bits to be punctured; determining a number of parity bit sets to be punctured based on the determined number of parity bits to be punctured; and acquiring a predetermined order of parity bit sets. 4246168 1 (GHMatters) P84756.AU.1 11/04/2013 [Figure 9] - - -innn nni.i o a a O 0 0 0 0 0 0 Oj-O -0 o a 0 0 0 O 0 0 0 0O O r- 0 0 O CD----D----D-C>---<D-C----------- D------------------- a O~4: r40 0 :0 0 0 0 CD CD 00 C: CBBBBC: D DC> -ri0lri -i0r 0 0 0 0j: c::) C.' 1 :O -: C-|C.:::..: C-:: C:)~~ ~ ~ +D ci.) C: ..I C) C:. ) oco-0 0 0 0 0 Or-' 0 0 0 0 0 0 0 0 0 0 00- ,-O O O 0 0 0 0 0 0 O r - 0 0 O Osr 0 0 * .- :. -n : Cr0 00O O ,- 0 0 0 0 0 0 0 Z3 O O C O - -- C O C O O 0 0 O O 0 0 0 0 0 0 0 0 OO 0 i. - . C)< > :) c : CI., I>nC> (Z)CD -- O s- ,- Oj O iOfO O &O O O1. O O O 0 -- 0 airO O O O 0 0 0 0 0 - -n O O O O O O O 0 >- OCD O O 0 0 0 0 0 0 0 OC> :C.-": C> (:" Z4 : > C) " * . *n --- i - -:" -.- ~C aZ: CD a> 0 0i) - O O - -- O O O -r -r--iO .. n O Oyns - O ,- 4 ,MOO .nO O OniO 0- 0 O Or O O 0 0 0 0 0 0r 0 0 0|r -:. r .. ro-::oOO11:+: C > C) CD CO O O D I,- Oz i :- O: C,- O l.- M I.A:. i.. CD ~ ~ ~ ~ ii 44 1.. .(Z. .z: C: = ).C)O i.M. -N.. P.M.. i+ 1 :r: CD C- CDO O O: CD C O D C> k' - O r I .". -s M IN I a .i::"'4 " . "I || ".E. q~t c:>'. c::;:: c> j .) l- T; rri:
Patent AU-2013204094-B2 (AU)
Title: Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis
Inventor: LING NICHOLAS CHI-KWAN
IPC: C07K14/47
Filed: 2013-04-11
Granted: 2016-02-11
Abstract: The present invention provides novel citrullinated peptides, their use in methods for aiding, assisting, improving, or facilitating the diagnosis or prognosis of rheumatic diseases such as rheumatoid arthritis (RA), and methods for identifying novel citrullinated peptides that are immunoreactive with anti-citrullinated protein antibodies (ACPAs). The present invention also provides methods for detecting rheumatoid factor (RF) using novel RF detection reagents as a means to aid, assist, improve, or facilitate the diagnosis or prognosis of rheumatic diseases such as RA. Kits comprising at least one of the novel citrullinated peptides and/or RF detection reagents of the present invention are also provided.